GLOBUS MEDICAL INC Overview
GMED market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
GMED price chart · 1M
- O
- 87.73
- H
- 87.92
- L
- 79.71
- C
- 81.36
- Vol
- 163,499.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $87.73
- Previous Close
- $87.05
- Day High
- $87.92
- Day Low
- $79.71
- 52 Week High
- $100.99
- 52 Week Low
- $60.35
- 7 Day Return
- -1.92%
- 30 Day Return
- +6.44%
- 90 Day Return
- -1.19%
- 1 Year Return
- +32.25%
- Daily Notional Volume
- $13.3M Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- 19.96 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.92 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.93 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 17.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $59.51 – $101.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- $103.23 Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $10.7B · P/B 2.57 · P/S 3.40.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
Globus Medical Reports Third Quarter 2026 Results and Announces Share Repurchase Program IncreaseFiscal.ai ·
Waters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance RaisedZacks Investment Research ·
BDX Gears Up to Report Q4 Results: How to Play the Stock?Zacks Investment Research ·
RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View UpZacks Investment Research ·
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/YZacks Investment Research ·
Reasons to Hold Veeva Systems Stock in Your Portfolio for NowZacks Investment Research ·
Is it the Right Time to Add Phibro Stock to Your Portfolio?Zacks Investment Research ·
Smith+Nephew Launches CARTIHEAL Implant Across Key European MarketsZacks Investment Research ·